Assistant Professor, Pathology, Yale University School of Medicine
Pathology
Dr. Natalia Buza, MD
|
|
Give Review
Natalia Buza practices Pathology. She went to medical school at University of Pcs Medical School. Natalia Buza has written publications. She has 36 publications published with PubMed. The lastest paper is: 'Mucinous Epithelial Tumors Arising from Ovarian Mature Teratomas: A Tissue Genotyping Study.' Natalia Buza accepts Medicare.
Publications
- Mucinous Epithelial Tumors Arising from Ovarian Mature Teratomas: A Tissue Genotyping Study.
- Intravenous leiomyomatosis revisited: an experience of 14 cases at a single medical center.
- A Series of Malignant Ovarian Cancers Arising From Within a Mature Cystic Teratoma: A Single Institution Experience.
- T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2.
- Egg donor pregnancy: a potential pitfall in DNA genotyping diagnosis of hydatidiform moles.
- Mitotically active microglandular hyperplasia of the cervix: a case series with implications for the differential diagnosis.
- Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study.
- T-DM1, a novel antibody-drug conjugate, is highly effective against primary HER2 overexpressing uterine serous carcinoma in vitro and in vivo.
- Immunohistochemistry and other ancillary techniques in the diagnosis of gestational trophoblastic diseases.
- Tissue identity testing of cancer by short tandem repeat polymorphism: pitfalls of interpretation in the presence of microsatellite instability.
- HER2/neu in Endometrial Cancer: A Promising Therapeutic Target With Diagnostic Challenges.
- Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice.
- Genotyping Diagnosis of Nongestational Choriocarcinoma Involving Fallopian Tube and Broad Ligament: A Case Study.
- Frequent KRAS mutation in complex mucinous epithelial lesions of the endometrium.
- Marked heterogeneity of HER2/NEU gene amplification in endometrial serous carcinoma.
- Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadj...
- Tubulin-?-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones.
- Class III ?-Tubulin Overexpression in Ovarian Clear Cell and Serous Carcinoma as a Marker for Poor Overall Survival after Platinum/Taxane Chemotherapy and Sensitivity ...
- Cancerous 'floater': a lesson learned about tissue identity testing, endometrial cancer and microsatellite instability.
- Partial Hydatidiform Mole: Histologic Parameters in Correlation With DNA Genotyping.
- Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.
- HER2/neu as a Potential Target for Immunotherapy in Gynecologic Carcinosarcomas.
- Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody.
- The significance of perineural invasion in early-stage cervical cancer.
- Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 ...
- Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.
- Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimer...
- Myoepithelial carcinoma of the breast: a clinicopathological and immunohistochemical study of 15 diagnostically challenging cases.
- HER-2/NEU overexpression in vulvar Paget disease: the Yale experience.
- Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder.
- Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201).
- Serum amyloid A: a novel biomarker for endometrial cancer.
- Comparative analysis of P16 and P53 expression in uterine malignant mixed mullerian tumors.
- Multinodular goiter and primary hyperparathyroidism: a circuitous route to diagnosing metastatic uveal melanoma.
- Langerhans cell histiocytosis: report of a single organ involvement in a child.
Doctors Specialties
- Anatomic Pathology
- Pathology
Accepted Insurances
Education
-
Yale-New Haven Hospital -
University of Pécs Medical School
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790962017 |
| Last Name Of The Provider | BUZA |
| First Name Of The Provider | NATALIA |
| View All |
Similar Doctors
|
|
Dr. Robert L. Camp, MD |
|
|
Dr. Joseph A. Madri, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Alfred J. Ranieri Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose Costa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fattaneh A. Tavassoli, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Lihui Qin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jon S. Morrow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jordan S. Pober, MD |
|
|
Dr. John M. Astle, MD
This Doctor is OpenDoctor Recommended.
|